...
首页> 外文期刊>Psychoneuroendocrinology: An International Journal >Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal.
【24h】

Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal.

机译:酒精戒断中血管加压素和心钠素的表观遗传调控和基因表达

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Disturbances of volume regulating peptides like vasopressin and atrial natriuretic peptide (ANP) have been described in early abstinent patients. Aim of the present study was to evaluate possible alterations of the promoter-related DNA methylation of the ANP and vasopressin precursor genes and the related mRNA-expression of these genes in early alcohol withdrawal. We analyzed blood samples of 57 healthy controls and of 111 patients suffering from alcohol dependence that were admitted for detoxification treatment. Promoter-related DNA methylation and mRNA-expression of vasopressin and ANP genes were assessed using real-time PCR. Vasopressin mRNA-expression was not statistically different between patients and controls. However, we found a significantly elevated promoter-related DNA methylation of the vasopressin gene in patients with alcohol dependence (Mann-Whitney U-test: Z=-2.178, p=0.029). ANP mRNA-expression was significantly elevated in alcoholic patients (Z=-6.240, p<0.001) while promoter-related DNA methylation of ANP was significantly decreased (Z=-2.282, p=0.023). Furthermore, promoter-related DNA methylation of ANP was significantly correlated to the extent of craving measured with the OCDS (r=-0.197, p=0.040). The findings of the present study show significant alterations of the mRNA-expression and promoter-related DNA methylation of vasopressin and especially ANP precursor genes in patients with alcohol dependence. Further studies focusing on longitudinal changes of epigenetic regulation and gene expression of both peptides are needed to clarify the pathophysiological role of these findings.
机译:在早期戒断患者中已经描述了诸如血管加压素和心钠素等体积调节肽的干扰。本研究的目的是评估早期戒酒后ANP和加压素前体基因的启动子相关DNA甲基化的可能改变以及这些基因的相关mRNA表达。我们分析了接受排毒治疗的57名健康对照者和111名酒精依赖患者的血液样本。血管加压素和ANP基因的启动子相关的DNA甲基化和mRNA表达使用实时PCR进行了评估。患者和对照组之间加压素mRNA的表达在统计学上没有差异。但是,我们发现酒精依赖患者中血管加压素基因的启动子相关DNA甲基化水平显着升高(Mann-Whitney U-test:Z = -2.178,p = 0.029)。酒精中毒患者的ANP mRNA表达显着升高(Z = -6.240,p <0.001),而启动子相关的ANP DNA甲基化显着降低(Z = -2.282,p = 0.023)。此外,启动子相关的ANP DNA甲基化与OCDS测得的渴望程度显着相关(r = -0.197,p = 0.040)。本研究的发现表明,酒精依赖患者中血管加压素,尤其是ANP前体基因的mRNA表达和启动子相关的DNA甲基化发生了显着变化。需要进一步研究侧重于表观遗传调控和两种肽的基因表达的纵向变化,以阐明这些发现的病理生理作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号